首页> 外文期刊>Nephron >Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study
【24h】

Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study

机译:低血清维生素D水平与腹膜透析患者亚临床动脉粥样硬化血管疾病的进展相关:一项潜在的多中心研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The prevalence of subclinical atherosclerosis and the main predictors of progression of this condition in patients undergoing peritoneal dialysis (PD) have been insufficiently investigated. Objectives and Method: Following a prospective, multicenter, observational design, we studied 237 patients who were treated with PD for >= 3 months, without any clinical background of cardiovascular (CV) disease. Our objectives were the following: (1) to investigate the prevalence of subclinical atherosclerosis, as compared to a control group of age-and sex-matched healthy individuals, and (2) to disclose PD technique-related predictors of progression of disease during a 24-month follow-up period. We used vascular ultrasound for characterization of subclinical atherosclerotic disease. Main Results: A total of 123 patients (51.9%) vs. 79 controls (33.5%) presented >= 1 carotid plaque, and 114 patients (48.3%) vs. 72 controls (30.5%) >= 1 femoral plaque, at baseline evaluation (p = 1 carotid plaque, and serum levels of 25OH vitamin D and C-reactive protein (CRP) at baseline as independent correlates of progression of atherosclerotic disease. On the contrary, PD technique-related variables did not show any association with this outcome. Conclusions: Atherosclerotic vascular disease is frequent among asymptomatic patients undergoing PD. Older age, pre-existent disease (assessed by vascular ultrasound), and serum levels of 25OH vitamin D and CRP are independent markers of the progression of this condition. These findings may contribute to improve identification of subpopulations with a high risk of CV events, deserving intensified measures of prevention. (C) 2017 S. Karger AG, Basel
机译:背景:亚临床动脉粥样硬化的患病率和在经过腹膜透析(PD)的患者中这种病症的进展的主要预测因子已经不够。目的和方法:遵循前瞻性,多中心,观测设计,我们研究了237名患者用PD治疗> = 3个月,没有任何临床背景的心血管(CV)疾病。我们的目标是以下:(1)探讨亚临床动脉粥样硬化的患病率,与年龄和性匹配的健康个体的对照组相比,(2)透露在A期间疾病进展的PD技术相关预测因素。 24个月的随访期。我们使用血管超声以表征亚临床动脉粥样硬化疾病。主要结果:共123名患者(51.9%)对照(51.9%)对照(33.5%)呈现> = 1颈斑,114名患者(48.3%)对照(30.5%)> = 1股股骨斑块,在基线下评价(P = 1颈斑块,以及基线中的250 oh维生素D和C反应蛋白(CRP)的血清水平作为动脉粥样硬化疾病的进展的独立相关性。相反,PD技术有关的变量没有显示任何关联结果。结论:在接受Pd的无症状患者中频繁发生动脉粥样硬化血管疾病。年龄较大的年龄,预活性疾病(通过血管超声评估),以及血清250型维生素D和CRP的血清水平是这种情况的自主标记。这些发现可能有助于改善具有高CV事件风险的群体的鉴定,值得加剧预防措施。(c)2017年karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号